Cybin (CYBN.NE) announced they have entered a drug development agreement with Catalent (NYSE: CTLT). Catalent is a global provider for advanced delivery technologies, development, and manufacturing solutions for…
Psychedelics
Revive Therapeutic (RVV.C) announced they have received positive results from a pre-clinical study evaluating the efficacy of psilocybin for the treatment of mild traumatic brain injury (TBI) in a rodent model of…
TBI 2X Stanley Cup winner Daniel Carcillo recently announced his Chicago-based company Wesana Health is set to go public next month. The company completed a $4M CAD convertible note…
Early money Generating revenue as a new company is almost always difficult. It typically takes time to build up a loyal customer base, execute marketing campaigns and create awareness…
Cybin (CYBN.NE) announced they had completed their 20th pre-clinical study and are progressing their CYB003 and CYB004 proprietary psychedelic molecules into studies that will enable them to be tested…
Red Light Holland (TRIP.C) has completed the sale and import of the Company’s iMicrodose psychedelic truffles packs from the Netherlands to Canada. The transaction was made possible via the…
Pure Extracts Technologies (PULL.C) subsidiary Pure Mushrooms placed its first order of functional mushrooms from its B.C.-based supplier. Pure Mushrooms has three functional mushroom formulations, each of which come…
Shamans among the machines In his 1999 lecture titled ‘Shamans Among the Machines’ Terence McKenna pointed out that “as far as people and machines are concerned, it was Ludwig…
Core One Labs (COOL.C) will begin trading on the OTC Pink Open Market (also known as OTC Pink or Pink Sheets) under the ticker symbol “CLABF”. Core One made…
Core One Labs (COOL.C) announced they have acquired all outstanding share capital of Bluejay Mental Health, a specialty medical clinic with an integrated telehealth platform. Bluejay’s integrated telehealth platform…